LOXICOM- meloxicam suspension

Země: Spojené státy

Jazyk: angličtina

Zdroj: NLM (National Library of Medicine)

Aktivní složka:

meloxicam (UNII: VG2QF83CGL) (meloxicam - UNII:VG2QF83CGL)

Dostupné s:

Norbrook Laboratories Limited

INN (Mezinárodní Name):

meloxicam

Složení:

meloxicam 1.5 mg in 1 mL

Podání:

ORAL

Druh předpisu:

PRESCRIPTION

Terapeutické indikace:

Loxicom Oral Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. Dogs with known hypersensitivity to meloxicam should not receive Loxicom Oral Suspension. Do not use Loxicom Oral Suspension in cats. Acute renal failure and death have been associated with the use of meloxicam in cats.

Přehled produktů:

Loxicom Oral Suspension 1.5 mg/mL: 10, 32 and 100 mL bottles with small and large dosing syringes. Storage: Store at controlled room temperature 68-77°F (20-25°C). Excursions permitted between 59°F and 86°F (15°C and 30°C). Brief exposure to temperature up to 104° F (40°C) may be tolerated provided the mean kinetic temperature does not exceed 77°F (25°C); however such exposure should be minimized. Made in the UK. Manufactured by: Norbrook Laboratories Limited Newry, BT35 6PU, Co. Down, Northern Ireland Loxicom® is a registered trademark of Norbrook Laboratories Limited U.S. Patent No. 9,399,013 083670I01

Stav Autorizace:

Abbreviated New Animal Drug Application

Charakteristika produktu

LOXICOM- MELOXICAM SUSPENSION
NORBROOK LABORATORIES LIMITED
----------
PROFESSIONAL INSERT
Approved by FDA under ANADA # 200-497
LOXICOM
(MELOXICAM ORAL SUSPENSION)
1.5 MG/ML
Non-steroidal anti-inflammatory drug for oral use in dogs only
CAUTION: Federal law restricts this drug to use by or on the order of
a licensed
veterinarian.
WARNING: Repeated use of meloxicam in cats has been associated with
acute renal
failure and death. Do not administer additional injectable or oral
meloxicam to cats.
See Contraindications, Warnings, and Precautions for detailed
information.
DESCRIPTION:
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the
oxicam class. Each
milliliter of Loxicom® Oral Suspension contains meloxicam equivalent
to 1.5 milligrams
and sodium benzoate (1.5 milligrams) as a preservative. The chemical
name for
Meloxicam is
4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-
carbox-amide-1, 1-dioxide. The formulation is a yellowish viscous
suspension.
INDICATIONS:
Loxicom Oral Suspension is indicated for the control of pain and
inflammation associated
with osteoarthritis in dogs.
DOSAGE AND ADMINISTRATION:
Always provide client information sheet with prescription. Carefully
consider the potential
benefits and risk of Loxicom Oral Suspension and other treatment
options before
deciding to use Loxicom Oral Suspension. Use the lowest effective dose
for the shortest
duration consistent with individual response. Loxicom Oral Suspension
should be
®
administered initially at 0.09 mg/lb (0.2 mg/kg) body weight only on
the first day of
treatment. For all treatments after day 1, Loxicom Oral Suspension
should be
administered once daily at a dose of 0.045 mg/lb (0.1 mg/ kg). The
syringes are
calibrated to deliver the daily maintenance dose in lbs. Because the
first dose (0.2
mg/kg) is two times the amount of the daily maintenance dose (0.1
mg/kg), two syringes
containing the 0.1 mg/kg dose should be administered at the first
dose.
DIRECTIONS FOR ADMINISTRATION:
Loxicom Oral Suspension is pack